Dr. Andrew J. Klein, MD
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- Hahnemann University College of Medicine (2001)
- Years since graduation
- 25
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 732
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2001Medical school: Hahnemann University College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
GA license 074671 -
Cardiovascular Disease Physician
GA license 074671
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Piedmont Hospital, Inc Atlanta, GA
- Piedmont Newton Hospital Covington, GA
- Piedmont Rockdale Hospital Conyers, GA
- St Marys Good Samaritan Hospital Greensboro, GA
- Putnam General Hospital Eatonton, GA
Medical groups
- Piedmont Cardiology of Atlanta, LLC (481 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 732
- Services billed
- 1,963
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 560 | 438 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 256 | 232 |
| Established patient office or other outpatient visit, 40-54 minutes | 170 | 138 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 111 | 108 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 92 | 66 |
| Critical care, first 30-74 minutes | 87 | 41 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 81 | 77 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 76 | 56 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 68 | 67 |
| New patient office or other outpatient visit, 45-59 minutes | 50 | 50 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Atlanta, GA | 635 |
| Metoprolol Succinate Other prescribers in Atlanta, GA | 499 |
| Atorvastatin Calcium Other prescribers in Atlanta, GA | 497 |
| Rosuvastatin Calcium Other prescribers in Atlanta, GA | 383 |
| Amlodipine Besylate Other prescribers in Atlanta, GA | 344 |
| Losartan Potassium Other prescribers in Atlanta, GA | 272 |
| Furosemide Other prescribers in Atlanta, GA | 220 |
| Carvedilol Other prescribers in Atlanta, GA | 210 |
| Lisinopril Other prescribers in Atlanta, GA | 204 |
| Eliquis (apixaban) Other prescribers in Atlanta, GA | 200 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 11 companies reported 32 payments worth $2,857 in total to this clinician.
| Endovascular Engineering Inc. | $1,913 |
|---|---|
| Abiomed | $258 |
| Novartis Pharmaceuticals Corporation | $243 |
| Chiesi USA, Inc. | $133 |
| Angiodynamics, Inc. | $132 |
| Boston Scientific Corporation | $52.06 |
| E.r. Squibb & Sons, L.l.c. | $36.53 |
| Bridgebio Pharma, Inc. | $32.08 |
| Travel and Lodging | $1,638 |
|---|---|
| Food and Beverage | $1,219 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Endovascular Engineering Inc. Jun 9, 2025 | Travel and Lodging Helo Thrombectomy System · Novel Catheter Thrombectomy Device · travel to Boston, MA · in-kind | $1,152 |
| Endovascular Engineering Inc. Nov 6, 2025 | Travel and Lodging Helo Thrombectomy System · Novel Catheter Thrombectomy Device · travel to Las Vegas, NV · in-kind | $486 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 4 companies. The companies reported $54,520 in research payments for these studies, mostly to the institutions running them.
- Engulf
Endovascular Engineering Inc. - Prospective, Multi-center, Single-arm Study of the Shockwave Medical Peripheral Intravascular Lithotripsy (IVL) System for Treatment of Calcified Peripheral Arterial Disease (PAD) in Below-the-Knee (BTK) Arteries
Shockwave Medical, Inc - Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism
Boston Scientific Corporation · Active, not recruiting · NCT04790370 - NCT04227899--LIFE-BTK Randomized Controlled Trial
Abbott Laboratories
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.